BioLineRx (BLRX) Shares Issued: 2023-2025
- BioLineRx's Shares Issued was N/A to $2.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $27.2 million, marking a year-over-year change of. This contributed to the annual value of $19.2 million for FY2024, which is 36.44% up from last year.
- Latest data reveals that BioLineRx reported Shares Issued of $2.9 million as of Q2 2025, which was down 73.29% from $10.7 million recorded in Q1 2025.
- In the past 5 years, BioLineRx's Shares Issued registered a high of $13.9 million during Q4 2024, and its lowest value of -$207,000 during Q3 2024.
- In the last 3 years, BioLineRx's Shares Issued had a median value of $6.8 million in 2025 and averaged $6.9 million.
- Over the last 5 years, BioLineRx's Shares Issued had its largest YoY gain of 13.71% in 2024, and its largest YoY loss of 110.92% in 2024.
- Over the past 3 years, BioLineRx's Shares Issued (Quarterly) stood at $12.2 million in 2023, then climbed by 13.71% to $13.9 million in 2024, then reached $2.9 million in 2025.
- Its Shares Issued was $2.9 million in Q2 2025, compared to $10.7 million in Q1 2025 and $13.9 million in Q4 2024.
